GL1X · GenesisL1 explorer

MolNFT v1 · #149993 · protein

Human JAK1 kinase domain in complex with inhibitor

6GGH · Tyrosine-protein kinase JAK1: “Human JAK1 kinase domain in complex with inhibitor”. X-ray diffraction, 1 ligand (EYQ), 3 pockets (best druggability 0.77). MolNFT v1 #149993 on GenesisL1: 3D structure, binding sites and pockets in…

PDB
6GGH
Type
protein
Length
568 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tyrosine-protein kinase JAK1
EC
2.7.10.2
UniProt
P23458
Ligands
EYQ
Pockets
3 · best druggability 0.77

Structure

x-ray diffraction · 2 distinct chains · 43% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATyrosine-protein kinase JAK1 (EC 2.7.10.2)protein28642% helix, 19% strandP23458
BTyrosine-protein kinase JAK1 (EC 2.7.10.2)protein28243% helix, 20% strandP23458

Ligands and binding sites

  • EYQ · ~{N}-[5-methyl-4-[7-[[(2~{R})-2-(4-methylpiperazin-1-yl)propanoyl]amino]-1~{H}-indol-3-yl]pyrimidin-2-yl]cyclopropanecarboxamide · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17290.770.8263EYQ
26700.740.8060EYQ
3520.250.7316empty

Interfaces

1 interface between chains.

  • A–B · 985 Ų buried · 14 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 modified (phosphorylation).

Compared structures

  • 6GGH · Human jak1 kinase domain in complex with inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.